- Supported exchanges /
- F /
- BXT.F
BIONXT SOLUTIONS INC. (BXT F) stock market data APIs
BioNxt Solutions Inc. engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains. In addition, the company offers psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. Further, it provides analytical testing and consulting services. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
BIONXT SOLUTIONS INC. Financial Data Overview
0.158 | |
0.158 | |
- | |
0.1585 | |
0.158 | |
0.106-0.54 | |
19 182 K | |
113 M | |
30 637 | |
0.661 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
BIONXT SOLUTIONS INC. Fundamental Data is available in our Financial Data APIs
- Net Revenue 30 637
- EBITDA -5 003 140
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get BIONXT SOLUTIONS INC. Earnings via APIs
- Latest Release 2024-11-01
- EPS/Forecast NaN
Get BIONXT SOLUTIONS INC. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: